Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Chemical composition and fumigant acaricidal activity of Salvia officinalis essential oil against Rhipicephalus microplus (Acari: Ixodidae).

Created on 30 Aug 2026

Authors

Tayeb Mahi, Lalia Ammar, Narimen Madouni, Tara Canelo, Raul Bonal

Published in

Experimental & applied acarology. Volume 97. Issue 3. Aug 29, 2026. Epub Aug 29, 2026.

Abstract

Ticks are major ectoparasites of livestock worldwide, causing severe economic losses through blood feeding, reduced productivity, and the transmission of several diseases. The intensive use of synthetic acaricides has led to resistance in tick populations and raised concerns about environmental contamination and animal health. Consequently, there is increasing interest in plant-derived products as safer and more sustainable alternatives for tick management. This study investigated the chemical composition and fumigant acaricidal activity of Salvia officinalis essential oil against the tick Rhipicephalus microplus (Acari: Ixodidae). A total of 36 compounds were identified by gas chromatography coupled with mass spectrometry (GC-MS). The major constituents were dextro-camphor (26.90%), linalool (20.85%), and eucalyptol (20.37%), indicating a predominance of oxygenated monoterpenes. The essential oil exhibited marked fumigant toxicity against adult ticks under laboratory conditions. The median lethal concentration (LC₅₀) values were 3.19 and 1.89 µL L-¹ air after 12 h and 24 h of exposure, respectively. The median lethal time (LT₅₀) ranged from 26.31 h at the lowest concentration (1.66 µL L-¹ air) to 1.50 h at the highest concentration (26.66 µL L-¹ air), showing a clear dose- and time-dependent effect. These findings suggest that S. officinalis essential oil could be a promising botanical fumigant for controlling R. microplus, with potential applications in integrated tick management strategies.

PMID:
42667431
Bibliographic data and abstract were imported from PubMed on 30 Aug 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 9
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement